Jouett Noah P, Smith Michael L, Watenpaugh Donald E, Siddiqui Maryam, Ahmad Maleeha, Siddiqui Farrukh
Institute for Cardiovascular and Metabolic Disease, University of North Texas Health Science Center, Fort Worth, Texas.
Sleep Consultants of Texas, Fort Worth, Texas.
Physiol Rep. 2017 May;5(9). doi: 10.14814/phy2.13254.
Central Sleep Apnea (CSA) is characterized by intermittent apneas and hypopneas during sleep that result from absent central respiratory drive. CSA occurs almost exclusively during non-rapid-eye-movement (NREM) sleep due to enhanced neuronal ventilatory drive during REM sleep that makes central apneas highly unlikely to form. A 45-year-old obese African American female presented with co-existing Obstructive Sleep Apnea (OSA) and CSA, not in the form of mixed or complex sleep apnea. Peculiarly, her CSA occurred only during rapid-eye-movement (REM) sleep, which is exceedingly rare. The patient's CSA was resolved when appropriate positive airway pressure (PAP) was prescribed. Our patient remains stable and has reported significant benefit from PAP usage. We offer possible neuro-physiological mechanisms herein, including enhanced loop gain and/or malfunction or malformation of the pre-Botzinger nucleus or other neurological process, that could explain the unique findings of this case.
中枢性睡眠呼吸暂停(CSA)的特征是睡眠期间出现间歇性呼吸暂停和呼吸浅慢,这是由于中枢呼吸驱动缺失所致。CSA几乎仅在非快速眼动(NREM)睡眠期间发生,因为快速眼动(REM)睡眠期间神经元通气驱动增强,使得中枢性呼吸暂停极不可能形成。一名45岁肥胖的非裔美国女性同时患有阻塞性睡眠呼吸暂停(OSA)和CSA,但并非混合性或复杂性睡眠呼吸暂停的形式。特别的是,她的CSA仅在快速眼动(REM)睡眠期间出现,这极为罕见。当给予适当的气道正压通气(PAP)治疗时,患者的CSA得到缓解。我们的患者病情保持稳定,并报告使用PAP有显著益处。我们在此提供了可能的神经生理机制,包括增强的环路增益和/或前包钦格复合体或其他神经过程的功能障碍或畸形,这些机制可以解释该病例的独特发现。